Public Genetic Blueprints Normalize Enhancement

When prominent geneticists publish annotated polygenic lists or 'recipes' on social networks, those artifacts shift from academic curiosities into public blueprints that make embryo selection and enhancement easier to imagine and commercialize. That normalization speeds uptake by clinicians, fertility clinics and private actors and reframes enhancement as an engineering project rather than a taboo ethics problem. — If true, public blueprints change who can act (fertility markets, start‑ups, regulators) and accelerate political and regulatory pressure around embryo selection, gene editing, inequality and consent.